Thiazoline derivatives as selective androgen receptor modulators (SARMS)

Details for Australian Patent Application No. 2004249697 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Ng, Raymond A.; Sui, Zhihua

Agent Shelston IP

Pub. Number AU-B-2004249697

PCT Pub. Number WO2004/113309

Priority 60/478,712 13.06.03 US

Filing date 12 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 22 April 2010

International Classifications

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

C07D 277/12 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/113309 Priority application(s): WO2004/113309

22 April 2010 Application Accepted

  Published as AU-B-2004249697

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249698-Quinolyl amide derivatives as CCR-5 antagonists

2004249695-Welded item, method for welding two layers of thermoplastic material, method for installing a valve, and ball